| 15.41 -0.76 (-4.7%) | 08-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 19.62 | 1-year : | 21.57 |
| Resists | First : | 16.8 | Second : | 18.46 |
| Pivot price | 15.96  |
|||
| Supports | First : | 14.1 | Second : | 11.73 |
| MAs | MA(5) : | 15.41 |
MA(20) : | 16.09 |
| MA(100) : | 17.99 |
MA(250) : | 21.43 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 47 |
D(3) : | 40.1 |
| RSI | RSI(14): 42.6 |
|||
| 52-week | High : | 30.27 | Low : | 14.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MIR ] has closed above bottom band by 30.8%. Bollinger Bands are 2.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.34 - 16.43 | 16.43 - 16.48 |
| Low: | 15.18 - 15.29 | 15.29 - 15.36 |
| Close: | 15.26 - 15.42 | 15.42 - 15.52 |
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Wed, 05 Aug 2026
Mirion Technologies Inc (MIR) Shares Fall 4.7% -- What GF Score of 55 Tells Investors - GuruFocus
Thu, 30 Jul 2026
Mirion Technologies (MIR) Stock Falls As Acquisitions Mask Modest Organic Growth - sahmcapital.com
Wed, 29 Jul 2026
Mirion Technologies, Inc. Q2 2026: Revenue $266.8M, EPS $0.03— 10-Q Summary - TradingView
Wed, 29 Jul 2026
Mirion Technologies (NYSE: MIR) Q2 2026 revenue reaches $266.8M - Stock Titan
Wed, 29 Jul 2026
Mirion Technologies, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:MIR) 2026-07-29 - Seeking Alpha
Tue, 28 Jul 2026
Earnings Flash (MIR) Mirion Technologies, Inc. Reports Q2 Revenue $266.8M, vs. FactSet Est of $269.3M - marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Industrials
|
|
|
Industry:
Industrial - Machinery
|
|
| Shares Out | 245 (M) |
| Shares Float | 225 (M) |
| Held by Insiders | 3.4 (%) |
| Held by Institutions | 112.5 (%) |
| Shares Short | 34,650 (K) |
| Shares Short P.Month | 28,980 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.51 |
| Profit Margin | 2.5 % |
| Operating Margin | 1.4 % |
| Return on Assets (ttm) | 1.2 % |
| Return on Equity (ttm) | 1.5 % |
| Qtrly Rev. Growth | 27.5 % |
| Gross Profit (p.s.) | 1.88 |
| Sales Per Share | 4 |
| EBITDA (p.s.) | 0.84 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 127 (M) |
| Levered Free Cash Flow | 68 (M) |
| PE Ratio | 154.09 |
| PEG Ratio | 0 |
| Price to Book value | 2.04 |
| Price to Sales | 3.84 |
| Price to Cash Flow | 29.78 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|